What is the current valuation of the US std testing-devices market?

The market valuation was $1742.17 Million in 2024. Read More

What is the projected market size for the US std testing-devices market by 2035?

The market is projected to reach $3170.0 Million by 2035. Read More

What is the expected CAGR for the US std testing-devices market during the forecast period 2025 - 2035?

The expected CAGR is 5.59% during the forecast period. Read More

Which companies are the key players in the US std testing-devices market?

Key players include Abbott Laboratories, Roche Diagnostics, Thermo Fisher Scientific, Siemens Healthineers, Hologic Inc, BD, Cepheid, and Bio-Rad Laboratories. Read More

What are the main product types in the US std testing-devices market?

Main product types include Test Kits, Equipment, and Consumables. Read More

How do serological tests compare to molecular tests in terms of market valuation?

Serological tests were valued at $300.0 - $600.0 Million, while molecular tests were valued at $500.0 - $1000.0 Million. Read More

What is the market valuation for rapid tests in the US std testing-devices market?

Rapid tests were valued between $600.0 and $1100.0 Million. Read More

Which end-user segment holds the highest market valuation in the US std testing-devices market?

Hospitals hold the highest market valuation, ranging from $600.0 to $1100.0 Million. Read More

What is the valuation range for HIV testing in the US std testing-devices market?

HIV testing was valued between $600.0 and $1100.0 Million. Read More

What is the valuation for hepatitis testing in the US std testing-devices market?

Hepatitis testing was valued between $392.17 and $720.0 Million. Read More

US STD Testing Devices Market

US STD Testing Devices Market Research Report By Type of Test (Serological Tests, Molecular Tests, Rapid Tests, Nucleic Acid Amplification Tests), By End User (Hospitals, Diagnostic Laboratories, Home Care Settings, Public Health Organizations), By Product Type (Test Kits, Equipment, Consumables) and By Application (Chlamydia Testing, Gonorrhea Testing, Syphilis Testing, HIV Testing, Hepatitis Testing) - Growth & Industry Forecast 2025 To 2035

Forecast Period

2025 - 2035

CAGR

5.59%

2024 Market Size

$ 1,742.17 Million

2035 Market Size

$ 3,170 Million

Healthcare ● Updated August 2026 Report ID: MRFR/HC/17986-HCR | Pages: 100 | Author: Vikita Thakur, Garvit Vyas

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Pharmaceutical, BY Type (USD Million)
  1. 4.1.1 Serological Tests
  2. 4.1.2 Molecular Tests
  3. 4.1.3 Rapid Tests
  4. 4.1.4 Nucleic Acid Amplification Tests
2. 4.2 Pharmaceutical, BY End User (USD Million)
  1. 4.2.1 Hospitals
  2. 4.2.2 Diagnostic Laboratories
  3. 4.2.3 Home Care Settings
  4. 4.2.4 Public Health Organizations
3. 4.3 Pharmaceutical, BY Product Type (USD Million)
  1. 4.3.1 Test Kits
  2. 4.3.2 Equipment
  3. 4.3.3 Consumables
4. 4.4 Pharmaceutical, BY Application (USD Million)
  1. 4.4.1 Chlamydia Testing
  2. 4.4.2 Gonorrhea Testing
  3. 4.4.3 Syphilis Testing
  4. 4.4.4 HIV Testing
  5. 4.4.5 Hepatitis Testing
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Pharmaceutical
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Pharmaceutical
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Abbott Laboratories (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Roche Diagnostics (CH)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Thermo Fisher Scientific (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Siemens Healthineers (DE)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Hologic Inc (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 BD (Becton, Dickinson and Company) (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Cepheid (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Bio-Rad Laboratories (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY TYPE
3. 6.3 US MARKET ANALYSIS BY END USER
4. 6.4 US MARKET ANALYSIS BY PRODUCT TYPE
5. 6.5 US MARKET ANALYSIS BY APPLICATION
6. 6.6 KEY BUYING CRITERIA OF PHARMACEUTICAL
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF PHARMACEUTICAL
9. 6.9 DRIVERS IMPACT ANALYSIS: PHARMACEUTICAL
10. 6.10 RESTRAINTS IMPACT ANALYSIS: PHARMACEUTICAL
11. 6.11 SUPPLY / VALUE CHAIN: PHARMACEUTICAL
12. 6.12 PHARMACEUTICAL, BY TYPE, 2024 (% SHARE)
13. 6.13 PHARMACEUTICAL, BY TYPE, 2024 TO 2035 (USD Million)
14. 6.14 PHARMACEUTICAL, BY END USER, 2024 (% SHARE)
15. 6.15 PHARMACEUTICAL, BY END USER, 2024 TO 2035 (USD Million)
16. 6.16 PHARMACEUTICAL, BY PRODUCT TYPE, 2024 (% SHARE)
17. 6.17 PHARMACEUTICAL, BY PRODUCT TYPE, 2024 TO 2035 (USD Million)
18. 6.18 PHARMACEUTICAL, BY APPLICATION, 2024 (% SHARE)
19. 6.19 PHARMACEUTICAL, BY APPLICATION, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TYPE, 2025-2035 (USD Million)
  2. 7.2.2 BY END USER, 2025-2035 (USD Million)
  3. 7.2.3 BY PRODUCT TYPE, 2025-2035 (USD Million)
  4. 7.2.4 BY APPLICATION, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US STD Testing Devices Market Segmentation

US STD Testing Devices Market By Type (USD Million, 2025-2035)

Serological Tests
Molecular Tests
Rapid Tests
Nucleic Acid Amplification Tests

US STD Testing Devices Market By End User (USD Million, 2025-2035)

Hospitals
Diagnostic Laboratories
Home Care Settings
Public Health Organizations

US STD Testing Devices Market By Product Type (USD Million, 2025-2035)

Test Kits
Equipment
Consumables

US STD Testing Devices Market By Application (USD Million, 2025-2035)

Chlamydia Testing
Gonorrhea Testing
Syphilis Testing
HIV Testing
Hepatitis Testing

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”